## Abstract Three groups of children with acute lymphoblastic leukemia (ALL) were treated with intermittent cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP). Group A (no prior relapse) and Group B (prior singleβagent relapse) received COAP after 12 months on another chemot
A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia
β Scribed by Dr. M. J. Keating; T. L. Smith; K. B. McCredie; G. P. Bodey; E. M. Hersh; J. U. Gutterman; E. Gehan; E. J. Freireich
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 996 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty patients with acute granulocytic leukemia were treated with ARA-C (100 mg/m2 IV during 5 days) and RBD (100 mg/m\*/day during 3 days). Twentytwo patients with AML and eight with APML were treated. The drugs always induced severe pancytopenia lasting an average of 18 days. Sixteen patients ach
One hundred-sixty-three children with acute nonlymphocytic leukemia (ANLL) were treated with a multiple-drug induction program (PATCO) consisting of prednisone (PDN), cytosine arabinoside ((Ara-C), 6-thioguanine (6-TG), cyclophosphamide (CPM), and Oncovin (VCR). Ninety-six, 59%, obtained a remission
## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with Lβasparaginase and cytosine arabinoside (1βΞ²βDβarabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1
Fifteen newly diagnosed unselected adult patients with acute nonlymphocytic leukemia were treated in a pilot study of the combination of vincristine, cytosine arabinoside, 6-thioguanine, and daunorubicin (VAT-D) for remission induction therapy. Eleven of fifteen (75%) achieved a remission bone marro